The Neurodevelopmental and Motor Phenotype of SCA21 (ATX-TMEM240).
The Neurodevelopmental and Motor Phenotype of SCA21 (ATX-TMEM240).
复制标题
DOI:
10.1177/0883073820943488
复制
发表时间:
2020-12
影响因子:
1.9
通讯作者:
Wilson RB
中科院分区:
文献类型:
--
作者:
Burdekin ED;Fogel BL;Jeste SS;Martinez J;Rexach JE;DiStefano C;Hyde C;Safari T;Wilson RB
Spinocerebellar ataxia type 21 (SCA21/ATX-TMEM240) is a rare form of cerebellar ataxia that commonly presents with motor, cognitive, and behavioral impairments. Although these features have been identified as part of the clinical manifestations of SCA21, the neurodevelopmental disorders associated with SCA21 have not been well studied or described. Here we present extensive phenotypic data for three subjects from a SCA21 family in the United States. Genetic testing demonstrated the c.196 G>A (p.Gly66Arg) variant to be a second recurrent mutation associated with the disorder. Standardized developmental assessment revealed significant deficits in cognition, adaptive function, motor skills, and social communication with two of the subjects having diagnoses of Autism Spectrum Disorder, which has never been described in SCA21. Quantitative gait analysis showed markedly abnormal spatiotemporal gait variables indicative of poor gait control and cerebellar as well as non-cerebellar dysfunction. Clinical evaluation also highlighted a striking variability in clinical symptoms, with greater ataxia correlating with greater severity of neurodevelopmental disorder diagnoses. Notably, neurodevelopmental outcomes have improved with intervention over time. Taken together, this case series identifies that the manifestation of neurodevelopmental disorders is a key feature of SCA21 and may precede the presence of motor abnormalities. Furthermore, the coexistence of ataxia and neurodevelopmental disorders in these subjects suggests a role for spinocerebellar pathways in both outcomes. The findings in this study highlight the importance of evaluation of neurodevelopmental concerns in the context of progressive motor abnormalities and the need for timely intervention to ultimately improve quality of life for individuals with SCA21.
登录
查看更多内容
影响因子:
9.9
作者:
Beauchet, O.;Annweiler, C.;Allali, G.
通讯作者:
Allali, G.
DOI:
10.1044/2019_jslhr-s-18-0380
发表时间:
2019-09-01
影响因子:
2.6
作者:
Iuzzini-Seigel, Jenya
通讯作者:
Iuzzini-Seigel, Jenya
影响因子:
9.8
作者:
Sato, Nozomu;Amino, Takeshi;Mizusawa, Hidehiro
通讯作者:
Mizusawa, Hidehiro
影响因子:
38.1
作者:
Nonnekes, Jorik;Goselink, Rianne J. M.;Bloem, Bastiaan R.
通讯作者:
Bloem, Bastiaan R.
DOI:
10.1097/wno0b013e3181b416de
发表时间:
2009-09
期刊:
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
影响因子:
--
作者:
Paulson HL
通讯作者:
Paulson HL